State figures show abortions more than doubled in Massachusetts as telehealth and out‑of‑state patients surged, reshaping where people get care.

A black bear was filmed on a Waltham home's Ring camera standing on a deck. State wildlife officials advise removing bird feeders and securing trash as bears emerge from dens.

Lynnway Park, a fully leased waterfront industrial campus, sold for $40 million to North River Company. The site houses food‑service and logistics tenants and includes developable waterfront land.

Vanna Howard was sworn into the Massachusetts Senate on March 18, becoming the nation’s first Cambodian‑American state senator after a March 3 special election. Her victory gives Lowell a new voice on Beacon Hill.

Lt. Jennifer Penton is set to be arraigned April 2 in Worcester on charges tied to the death of recruit Enrique Delgado‑Garcia during academy boxing drills.

A 15-year-old was arrested after a Paris Street stabbing in East Boston that left a man with non-life-threatening injuries. Police recovered knives and a ski mask.

Cambridge Engine 4 was sent Wednesday to cover Medford's fire headquarters as crews battled a second‑alarm blaze on Central Avenue. Details remain limited.

More than 160 Harvard Club employees in Back Bay voted to join UFCW Local 1445 after a March NLRB election, citing low pay and no contract since June 2024.

A water main break in Jamaica Plain flooded streets and forced evacuations at daycares and businesses as crews work to make repairs.

The New Hampshire Supreme Court found a warrantless phone‑location search that located Logan Clegg in the 2022 Concord double murder unconstitutional and remanded the case for review.

A Boston resident admitted to participating in a multistate ring that used forged documents and DMV hoops to obtain hundreds of real driver’s licenses; sentencing is set for April 9, 2026.

A Saugus man and a passenger were arrested after a Jeep allegedly struck three people outside Icon nightclub; prosecutors initially filed assault and firearm charges but later dropped all charges in April 2026.

Aldeyra’s shares plunged about 70% after the FDA declined to approve reproxalap, the Lexington biotech’s lead dry‑eye candidate.